Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Apr 15, 2021

5250_rns_2021-04-15_0669af5b-5980-489c-a777-a3c1ac376ad1.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - Willis Towers Watson plc

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) ORD
Date of dealing 14 Apr 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,677,106 1.30% 163,297 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,100 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,755,565 1.36% 176,497 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 5 237.3440 USD
Purchase 7 235.3900 USD
Purchase 8 239.0937 USD
Purchase 12 235.8775 USD
Purchase 42 236.2204 USD
Purchase 51 235.8023 USD
Purchase 56 235.8678 USD
Purchase 58 235.6253 USD
Purchase 64 235.9362 USD
Purchase 76 235.5476 USD
Purchase 76 240.8700 USD
Purchase 77 235.8690 USD
Purchase 83 235.7892 USD
Purchase 100 235.5600 USD
Purchase 155 239.2000 USD
Purchase 200 238.9300 USD
Purchase 209 241.8300 USD
Purchase 224 236.0219 USD
Purchase 300 236.5500 USD
Purchase 300 240.8016 USD
Purchase 370 238.5872 USD
Purchase 371 238.0567 USD
Purchase 451 235.5121 USD
Purchase 774 236.9382 USD
Purchase 855 236.2344 USD
Purchase 1,000 238.1910 USD
Purchase 1,100 236.7709 USD
Purchase 1,604 236.3604 USD
Purchase 1,867 239.5670 USD
Purchase 2,045 236.7200 USD
Purchase 2,866 238.5869 USD
Purchase 4,699 236.8501 USD
Purchase 5,248 237.3696 USD
Purchase 5,510 237.5461 USD
Purchase 7,974 238.9447 USD
Purchase 8,057 238.9449 USD
Purchase 14,982 236.7064 USD
Purchase 20,769 237.8905 USD
Purchase 30,011 236.7199 USD
Sale 1 238.0100 USD
Sale 2 235.6300 USD
Sale 2 236.3000 USD
Sale 3 239.4400 USD
Sale 3 237.8366 USD
Sale 5 241.6200 USD
Sale 5 238.7880 USD
Sale 5 238.3250 USD
Sale 7 239.0671 USD
Sale 9 239.1766 USD
Sale 11 237.4222 USD
Sale 11 237.4536 USD
Sale 11 237.8590 USD
Sale 12 237.4262 USD
Sale 12 238.3404 USD
Sale 14 237.3650 USD
Sale 14 237.3625 USD
Sale 81 241.5776 USD
Sale 100 240.2300 USD
Sale 139 241.6320 USD
Sale 376 240.8155 USD
Sale 456 237.8567 USD
Sale 667 236.7726 USD
Sale 1,496 241.0443 USD
Sale 2,131 237.0729 USD
Sale 4,330 237.8283 USD
Sale 6,425 237.4071 USD
Sale 6,552 236.5907 USD
Sale 7,600 239.0107 USD
Sale 8,306 238.9146 USD
Sale 11,238 236.7200 USD
Sale 30,025 236.7206 USD
Sale 32,607 237.5811 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
SWAP Long 1 392,651,420.0000 USD
Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 15 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005520/en/

BARCLAYS PLC